- Home
- TMDE vs FBIOP Comparison
TMDE vs FBIOP Comparison
Compare TMDE & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDE
- FBIOP
- Stock Information
- Founded
- TMDE 2016
- FBIOP N/A
- Country
- TMDE Malaysia
- FBIOP United States
- Employees
- TMDE N/A
- FBIOP 101
- Industry
- TMDE Oil Refining/Marketing
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- TMDE Energy
- FBIOP Health Care
- Exchange
- TMDE Nasdaq
- FBIOP Nasdaq
- Market Cap
- TMDE N/A
- FBIOP N/A
- IPO Year
- TMDE 2025
- FBIOP N/A
- Fundamental
- Price
- TMDE $0.82
- FBIOP $7.90
- Analyst Decision
- TMDE
- FBIOP
- Analyst Count
- TMDE 0
- FBIOP 0
- Target Price
- TMDE N/A
- FBIOP N/A
- AVG Volume (30 Days)
- TMDE 302.4K
- FBIOP N/A
- Earning Date
- TMDE 05-14-2025
- FBIOP N/A
- Dividend Yield
- TMDE N/A
- FBIOP N/A
- EPS Growth
- TMDE N/A
- FBIOP N/A
- EPS
- TMDE 0.09
- FBIOP N/A
- Revenue
- TMDE $688,607,542.00
- FBIOP N/A
- Revenue This Year
- TMDE N/A
- FBIOP N/A
- Revenue Next Year
- TMDE N/A
- FBIOP N/A
- P/E Ratio
- TMDE $8.69
- FBIOP N/A
- Revenue Growth
- TMDE 8.77
- FBIOP N/A
- 52 Week Low
- TMDE $0.76
- FBIOP N/A
- 52 Week High
- TMDE $6.27
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- TMDE N/A
- FBIOP 74.91
- Support Level
- TMDE N/A
- FBIOP $6.43
- Resistance Level
- TMDE N/A
- FBIOP $7.00
- Average True Range (ATR)
- TMDE 0.00
- FBIOP 0.39
- MACD
- TMDE 0.00
- FBIOP 0.09
- Stochastic Oscillator
- TMDE 0.00
- FBIOP 96.95
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.